BOSTON SCIENTIFIC CORPORATION Financial and Nonfinancial Liabilities, Fair Value Disclosure
BOSTON SCIENTIFIC CORPORATION (BSX) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $1.46 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-03
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $1.46B.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $1.58B.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $1.70B.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $1.46B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.58B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $1.70B 10-Q · filed 2026-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |